Search

Search Constraints

You searched for: Author/Creator Kamenický, Peter

Search Results

1. A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis. (26th June 2018)

2. Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X‐Linked Hypophosphatemia: A Phase 3, Single‐Arm, International Trial. (1st October 2019)

3. Effects of cortisol on the heart: characterization of myocardial involvement in cushing's disease by longitudinal cardiac MRI T1 mapping. Issue 1 (9th July 2016)

4. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Issue 2 (13th January 2022)

5. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Issue 2 (13th January 2022)

6. Germline mutations in the new E1' cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma. Issue 11 (29th January 2020)

7. Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR. Issue 12 (17th November 2022)

8. Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia. Issue 2 (February 2020)

9. Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia. Issue 2 (February 2020)

10. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study. Issue 12 (December 2021)